Endotoxin (lipopolysaccharide, LPS) contamination in antibody preparations can confound in vivo experiments by triggering innate immune responses, causing fever, septic shock symptoms, or altering the very immune pathways you are trying to study. This guide explains what endotoxin is, why it matters for in vivo antibodies, and what levels are acceptable.
What Is Endotoxin?
Endotoxins are lipopolysaccharide (LPS) molecules from the outer membrane of Gram-negative bacteria. They are extremely heat-stable (not destroyed by autoclaving), resistant to pH extremes, and biologically active at nanogram quantities. Endotoxin activates Toll-like receptor 4 (TLR4) on macrophages and dendritic cells, triggering NF-κB signaling and pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6).
Why Endotoxin Matters for In Vivo Antibody Research
When you inject an antibody into a mouse for an in vivo experiment (tumor studies, autoimmune models, depletion studies), any co-injected endotoxin will:
- Activate the innate immune system independently of your antibody’s intended mechanism
- Confound results in immunology, oncology, and inflammation studies
- Cause acute toxicity symptoms: fever, weight loss, lethargy, and in severe cases, death
- Alter tumor growth kinetics by non-specifically activating tumor-associated macrophages
Critical Point
In immuno-oncology studies (e.g., anti-PD-1/PD-L1 checkpoint blockade in tumor-bearing mice), even moderate endotoxin contamination can mimic or mask the antibody’s therapeutic effect. A “response” driven by endotoxin-mediated immune activation is not a drug effect.
Acceptable Endotoxin Levels
| Application |
Acceptable Level |
Standard / Reference |
| In vivo research (mice) |
<1 EU/mg antibody |
Industry standard for research-grade in vivo antibodies |
| InVivo Plus grade |
<1 EU/mg (≥0.95 purity by SDS-PAGE) |
Enhanced purity for critical in vivo studies |
| Preclinical / GLP studies |
<0.5 EU/mg |
More stringent; facility-dependent |
| In vitro cell culture |
<10 EU/mg (generally acceptable) |
Higher tolerance; cells less sensitive than whole organism |
| Clinical (reference) |
<5 EU/kg body weight/hour |
FDA guideline for injectable biologics |
Endotoxin is measured in Endotoxin Units (EU) using the Limulus Amebocyte Lysate (LAL) assay. 1 EU ≈ 100 pg of E. coli LPS.
In Vivo Grade vs. Standard Research Grade Antibodies
| Feature |
Standard Research Grade |
In Vivo Grade (InVivoMAb / InVivo Plus) |
| Endotoxin |
Variable; often not tested |
<1 EU/mg (tested and certified) |
| Purity (SDS-PAGE) |
Typically >90% |
>95% (InVivo Plus) |
| Preservative |
May contain sodium azide (toxic in vivo) |
Azide-free; formulated in sterile PBS |
| Sterility |
Not guaranteed |
Sterile-filtered; suitable for injection |
| QC documentation |
COA with basic specs |
COA with endotoxin, purity, and functional data |
Warning: Sodium Azide
Standard research-grade antibodies often contain 0.02–0.1% sodium azide as a preservative. Sodium azide is toxic in vivo (lethal dose in mice is low). Never inject azide-containing antibodies into animals. Always check the formulation and use azide-free, in vivo-grade products.
How to Reduce Endotoxin in Your Own Preparations
- Use endotoxin-free labware. Autoclaved plastic is generally low-endotoxin. Glass must be depyrogenated (baked at 250°C for 30 min).
- Use endotoxin-free buffers. Prepare buffers with endotoxin-tested water and sterile-filter (0.22 µm).
- Commercial endotoxin removal kits. Polymyxin B-based resins or Triton X-114 phase separation can remove endotoxin from purified proteins, but recovery and activity loss must be assessed.
- Test before injecting. Run an LAL assay (gel-clot or kinetic turbidimetric) on your final preparation. Many core facilities offer this as a service.
Browse In Vivo Grade Antibodies →
中文
English
한국어
日本語
Español
Français
Русский
